Codes / ICD10CM / T38.80

T38.80 Poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by, adverse effect of and underdosing of unspecified hormones and synthetic substitutes

Summary

This condition encompasses adverse effects, poisoning, or underdosing related to hormones and their synthetic substitutes when the specific agent is not classified elsewhere. It includes reactions to these substances that are not assigned to more specific codes, covering scenarios where the exact hormone or substitute is unspecified.

Causes

The causes involve exposure to hormones or their synthetic substitutes, which may result from therapeutic use, accidental ingestion, or incorrect dosing. Adverse effects can arise from the pharmacological properties of these agents, while underdosing may stem from insufficient administration or non-adherence.

Risk Factors

  • Use of hormone therapies or substitutes for medical conditions
  • Polypharmacy involving hormonal agents
  • Incorrect dosing or administration
  • Individual sensitivity to hormonal substances
  • Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific hormone or agent involved and may include metabolic disturbances, endocrine imbalances, or organ-specific effects. Adverse reactions could manifest as hyper- or hypofunction of target systems, while underdosing may lead to inadequate therapeutic response.

Diagnosis

Diagnosis requires a thorough patient history, including medication use, clinical presentation, and laboratory findings. Documentation should specify whether the issue is poisoning, adverse effect, or underdosing, and note the absence of a more specific agent code.

Treatment Options

Treatment depends on the nature of the issue: poisoning may require decontamination or supportive care, adverse effects may involve discontinuation or dose adjustment, and underdosing may necessitate therapeutic optimization. Management is guided by the specific hormone involved and clinical severity.

Prognosis and Follow-Up

Prognosis varies based on the hormone, dose, and patient factors. Underdosing may lead to unresolved disease, while poisoning or adverse effects can cause temporary or permanent harm. Follow-up includes monitoring for resolution of symptoms and adjustment of therapy as needed.

Complications

Complications may include organ dysfunction, metabolic imbalances, or treatment failure. Severe cases of poisoning or adverse effects can result in long-term sequelae, while underdosing may worsen underlying conditions.

Lifestyle & Prevention

Prevention involves proper medication storage, adherence to prescribed dosing, and patient education on hormone therapy risks. Avoiding polypharmacy and regular monitoring can reduce adverse events.

When to Seek Professional Help

Seek medical attention for symptoms of poisoning (e.g., severe metabolic changes) or adverse effects (e.g., allergic reactions). Underdosing should be addressed if therapeutic goals are unmet or symptoms worsen.

Tips for Medical Coders

Document the specific hormone or substitute when known to ensure accurate coding. Use this code only when the agent is unspecified and not classified elsewhere. Include details on whether the issue is poisoning, adverse effect, or underdosing to support code assignment.

Book a walkthrough

T38.80 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.